PER 1.41% 7.0¢ percheron therapeutics limited

in trading halt, page-63

  1. 4,149 Posts.
    Based on these interim results, the Company will be following up interest from pharmaceutical companies in partnering the development of ATL1103 for Phase III clinical trials.”

    We have a drug here! and still there is room for improved findings GO ANP you good thing!!!!!!!!!!!!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.